Aims: We investigated whether the insertion/deletion (I/D) polymorphism of the ACE gene modified the adherence to ACE inhibitors as measured by the discontinuation of an ACE inhibitor, or addition of another antihypertensive drug. Methods: This was a cohort study among 239 subjects who started ACE inhibitor therapy. A Cox proportional hazard model was used to calculate relative risk (RR). Results: During follow-up there was no significant difference between subjects with the DD, ID or II genotype (DD vs II; RR= 1.17, 95%CI: 0.78, 1.77 and ID vs II; RR = 1.06, 95%CI: 0.73, 1.55) in adherence. Conclusions: The I/D polymorphism of the ACE gene does not influence the adherence to ACE inhibitors.

Additional Metadata
Keywords ACE gene, ACE inhibitors, Polymorphism
Persistent URL,
Journal British Journal of Clinical Pharmacology
Schelleman, H, Klungel, O.H, van Duijn, C.M, Witteman, J.C.M, Hofman, A, de Boer, A.C, & Stricker, B.H.Ch. (2005). Insertion/deletion polymorphism of the ACE gene and adherence to ACE inhibitors. British Journal of Clinical Pharmacology, 59(4), 483–485. doi:10.1111/j.1365-2125.2004.02332.x